PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
Breakthrough Non-Drug ADHD Treatment Gets FDA Approval

Breakthrough Non-Drug ADHD Treatment Gets FDA Approval

by PEPID Newsroom | Apr 19, 2019 | Alerts

Children living with attention hyperactivity disorder (ADHD) may soon experience non-pharmacologic relief through a breakthrough medical device. For children between the ages 7 and 12 and currently not on medication, the pocket-sized device works by delivering mild...

Recent Posts

  • Opioid Use Disorder in the Emergency Department: Buprenorphine Initiation, Naloxone Distribution, and the Warm Handoff on International Overdose Awareness Day
  • Dementia in the Emergency Department: Recognizing Delirium, Anticholinergic Burden, and the “Acting Different” Presentation
  • Heat-Related Illness in the Emergency Department: Recognition, Cooling, and the High-Risk Patient
  • EMS Week in Practice: Strengthening the Prehospital-to-ED Continuum for Better Patient Outcomes
  • Sleep Awareness Week: Why Sleep Health Should Be Part of Every Wellness Visit

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved